- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/18 - Growth hormones
Patent holdings for IPC class C12N 15/18
Total number of patents in this class: 122
10-year publication summary
|
3
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Opko Biologics Ltd. | 78 |
7 |
| Florida State University Research Foundation, Inc. | 774 |
4 |
| National Research Council of Canada | 1554 |
3 |
| Novagen Holding Corporation | 25 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4364 |
3 |
| Genentech, Inc. | 4005 |
2 |
| Pfizer Inc. | 3371 |
2 |
| Wyeth LLC | 653 |
2 |
| Amgen Inc. | 4129 |
2 |
| The Trustees of Columbia University in the City of New York | 3599 |
2 |
| Acceleron Pharma Inc. | 358 |
2 |
| Ambrx, Inc. | 182 |
2 |
| The Governors of the University of Alberta | 878 |
2 |
| Institute for Research in Biomedicine (IRB) | 39 |
2 |
| Minerva Biotechnologies Corporation | 113 |
2 |
| NGM Biopharmaceuticals, Inc. | 177 |
2 |
| Ottawa Hospital Research Institute | 108 |
2 |
| The Regents of the University of Colorado, a body corporate | 2690 |
2 |
| Transalgae Israel Ltd. | 14 |
2 |
| United Therapeutics Corporation | 310 |
2 |
| Other owners | 72 |